P-tau217 Shows Promise as Biomarker for Alzheimer Disease

FRIDAY, July 31, 2020 -- Plasma tau phosphorylated at threonine 217 (P-tau217) shows promise as a biomarker for Alzheimer disease (AD), according to a study published online July 28 in the Journal of the American Medical Association to coincide with...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news